PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.\', \'Vaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. krishana.gulla@nih.gov.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. daniel.gowetski@nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-07485-w
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35292666
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Advances in purification of SARS-CoV-2 spike ectodomain protein using high-throughput screening and non-affinity methods.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all